|Mr. James A. Mish||Chief Exec. Officer||1.14M||N/A||1964|
|Mr. Michael J. Zercher||Pres & COO||764.5k||N/A||1971|
|Mr. John E. Franzino||VP of Admin., CFO & Treasurer||408.9k||N/A||1957|
|Mr. John T. Brodfuehrer||Interim Director of HR||N/A||N/A||1958|
|Ms. Mei Kuo||Director of Communications & Investor Relations||N/A||N/A||N/A|
|Mr. Steven Przybyla||Gen. Counsel & Corp. Sec.||N/A||N/A||N/A|
|Mr. Henry Sicignano III, M.B.A., MBA||Consultant||N/A||N/A||1968|
|Mr. James C. Morrison||Technical Advisor & Regulatory Affairs Consultant||N/A||N/A||N/A|
22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
22nd Century Group, Inc.’s ISS Governance QualityScore as of April 30, 2021 is 7. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 6; Compensation: 9.